Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone

Tadej Petreski; Nejc Piko; Matevž Privšek; Tadej Zorman; Sebastjan Bevc

doi:10.12890/2020_001526

Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone

Eur J Case Rep Intern Med. 2020 Mar 3;7(4):001526. doi: 10.12890/2020_001526. eCollection 2020.

Authors

Tadej Petreski^{1

2}, Nejc Piko¹, Matevž Privšek³, Tadej Zorman³, Sebastjan Bevc^{1

2}

Affiliations

¹ Department of Nephrology, 4 Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
² Medical Faculty Maribor, University of Maribor, Maribor, Slovenia.
³ Centre for Emergency Medicine, University Medical Centre Maribor, Maribor, Slovenia.

Abstract

Amiodarone is an antiarrhythmic drug, in use from the 1960s, which acts on potassium transport in myocytes, causing a lengthening of the action potential and refractory period. Even though it is broadly prescribed, its use is limited by a relatively high occurrence of adverse reactions such as lung, thyroid or hepatic disease, skin changes and so on. The authors report a case of a female patient who was admitted due to chest pain. Due to the bluish skin pigmentation, other causes of amiodarone toxicity were investigated, and hyperthyroidism was detected. After amiodarone discontinuation and specific therapy, thyroid function returned to normal.

Learning points: Blue pigmentation of facial skin is an uncommon adverse effect of chronic amiodarone therapy that occurs in less than 3% of patients.When a patient is on chronic amiodarone therapy, signs of toxicity, such as hyperthyroidism, lung injury or hepatic disease, should be investigated.Regular liver and thyroid function tests and chest x-rays should be carried out on follow-up after initiation of amiodarone.

Keywords: Amiodarone; adverse drug reaction; atrial fibrillation; hyperthyroidism; skin pigmentation.